CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Fatty Acids Bind Tightly to the N-terminal Domain of Angiopoietin-like Protein 4 and Modulate Its Interaction with Lipoprotein Lipase

Robal, Terje, Larsson, Mikael, Martin, Miina, Olivecrona, Gunilla, Lookene, Aivar·2012·Journal of Biological Chemistry
DOI 10.1074/jbc.m111.303529
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.303529

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 58

  1. Labreuche, 2010, Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis. Systematic review and meta-regression analysis, Atherosclerosis, 212, 9, 10.1016/j.atherosclerosis.2010.02.011 · DOI
  2. De Caterina, 2010, Cholesterol-lowering interventions and stroke. Insights from a meta-analysis of randomized controlled trials, J. Am. Coll. Cardiol., 55, 198, 10.1016/j.jacc.2009.07.062 · DOI
  3. Fruchart, 2004, New risk factors for atherosclerosis and patient risk assessment, Circulation, 109, III15, 10.1161/01.CIR.0000131513.33892.5b · DOI
  4. Kannel, 2009, Triglycerides as vascular risk factors. New epidemiologic insights, Curr. Opin. Cardiol., 24, 345, 10.1097/HCO.0b013e32832c1284 · DOI · Paper page
  5. Yoshida, 2002, Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase, J. Lipid Res., 43, 1770, 10.1194/jlr.C200010-JLR200 · DOI · Paper page
  6. Lichtenstein, 2010, Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1, Biochim. Biophys. Acta, 1801, 415, 10.1016/j.bbalip.2009.12.015 · DOI
  7. Lichtenstein, 2010, Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages, Cell Metab., 12, 580, 10.1016/j.cmet.2010.11.002 · DOI · Paper page
  8. Wang, 2009, Lipoprotein lipase. From gene to obesity, Am. J. Physiol. Endocrinol. Metab., 297, E271, 10.1152/ajpendo.90920.2008 · DOI · Paper page
  9. Davies, 2012, New wrinkles in lipoprotein lipase biology, Curr. Opin. Lipidol., 23, 35, 10.1097/MOL.0b013e32834d0b33 · DOI
  10. Sukonina, 2006, Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue, Proc. Natl. Acad. Sci., 103, 17450, 10.1073/pnas.0604026103 · DOI · Paper page
  11. Xu, 2005, Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice, Proc. Natl. Acad. Sci. U.S.A., 102, 6086, 10.1073/pnas.0408452102 · DOI · Paper page
  12. Gealekman, 2008, Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production, Am. J. Physiol. Endocrinol. Metab., 295, E1056, 10.1152/ajpendo.90345.2008 · DOI
  13. Chomel, 2009, Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity, FASEB J., 23, 940, 10.1096/fj.08-115170 · DOI
  14. Nakayama, 2011, Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer. ANGPTL4 promotes venous invasion and distant metastasis, Oncol. Rep., 25, 929, 10.3892/or.2011.1176 · DOI
  15. Goh, 2010, Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing, J. Biol. Chem., 285, 32999, 10.1074/jbc.M110.108175 · DOI
  16. Yoon, 2000, Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation, Mol. Cell. Biol., 14, 5343, 10.1128/MCB.20.14.5343-5349.2000 · DOI · Paper page
  17. Ge, 2004, Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4, J. Biol. Chem., 279, 2038, 10.1074/jbc.M307583200 · DOI · Paper page
  18. Mandard, 2004, The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment, J. Biol. Chem., 279, 34411, 10.1074/jbc.M403058200 · DOI · Paper page
  19. Ge, 2005, Differential regulation and properties of angiopoietin-like proteins 3 and 4, J. Lipid Res., 46, 1484, 10.1194/jlr.M500005-JLR200 · DOI · Paper page
  20. Ge, 2004, Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4, J. Lipid Res., 45, 2071, 10.1194/jlr.M400138-JLR200 · DOI · Paper page
  21. Yin, 2009, Genetic variation in ANGPTL4 provides insights into protein processing and function, J. Biol. Chem., 284, 13213, 10.1074/jbc.M900553200 · DOI · Paper page
  22. Shan, 2009, The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms, J. Biol. Chem., 284, 1419, 10.1074/jbc.M808477200 · DOI · Paper page
  23. Lei, 2011, Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity, J. Biol. Chem., 286, 15747, 10.1074/jbc.M110.217638 · DOI · Paper page
  24. Lee, 2009, Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL), J. Biol. Chem., 284, 13735, 10.1074/jbc.M807899200 · DOI · Paper page
  25. Yau, 2009, A highly conserved motif within the N2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization, J. Biol. Chem., 284, 11942, 10.1074/jbc.M809802200 · DOI · Paper page
  26. Romeo, 2007, Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL, Nat. Genet., 39, 513, 10.1038/ng1984 · DOI · Paper page
  27. Bergö, 1996, Forms of lipoprotein lipase in rat tissues. In adipose tissue the proportion of inactive lipase increases on fasting, Biochem. J., 313, 893, 10.1042/bj3130893 · DOI
  28. Bergö, 2002, Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on, J. Biol. Chem., 277, 11927, 10.1074/jbc.M200325200 · DOI · Paper page
  29. Dutton, 2008, Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes, Br. J. Nutr., 100, 18, 10.1017/S0007114507882961 · DOI
  30. Kersten, 2000, Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene, J. Biol. Chem., 275, 28488, 10.1074/jbc.M004029200 · DOI · Paper page
  31. Georgiadi, 2010, Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor β/δ and protects against fatty acid-induced oxidative stress, Circ. Res., 106, 1712, 10.1161/CIRCRESAHA.110.217380 · DOI · Paper page
  32. Kaddatz, 2010, Transcriptional profiling identifies functional interactions of TGFβ and PPARβ/δ signaling. Synergistic induction of ANGPTL4 transcription, J. Biol. Chem., 285, 29469, 10.1074/jbc.M110.142018 · DOI
  33. Robciuc, 2010, Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample, J. Lipid Res., 51, 824, 10.1194/jlr.M002618 · DOI
  34. Smart-Halajko, 2010, The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk, Arterioscler. Thromb. Vasc. Biol., 30, 2277, 10.1161/ATVBAHA.110.212209 · DOI
  35. Mandard, 2006, The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity, J. Biol. Chem., 281, 934, 10.1074/jbc.M506519200 · DOI · Paper page
  36. Sonnenburg, 2009, GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4, J. Lipid Res., 50, 2421, 10.1194/jlr.M900145-JLR200 · DOI · Paper page
  37. Nilsson, S. K, Larsson, M., Lookene, A., Heeren, J., Olivercona, G., (2009) Triacylglycerol-rich lipoproteins' influence on the inactivation of lipoprotein lipase by angptl 3 and angptl 4. Abstracts of the XV International Symposium on Atherosclerosis, Boston, MA, June 14–18, 2009, p. e238 · DOI
  38. Bengtsson, 1980, Lipoprotein lipase. Mechanism of product inhibition, Eur. J. Biochem., 106, 557, 10.1111/j.1432-1033.1980.tb04603.x · DOI
  39. Bengtsson-Olivecrona, 1991, Phospholipase activity of milk lipoprotein lipase, Methods Enzymol., 197, 345, 10.1016/0076-6879(91)97160-Z · DOI
  40. Gill, 1989, Calculation of protein extinction coefficients from amino acid sequence data, Anal. Biochem., 182, 319, 10.1016/0003-2697(89)90602-7 · DOI
  41. Goldstein, 1983, Receptor-mediated endocytosis of low-density lipoprotein in cultured cells, Methods Enzymol., 98, 241, 10.1016/0076-6879(83)98152-1 · DOI
  42. van der Vusse, 2009, Albumin as fatty acid transporter, Drug Metab. Pharmakinet., 24, 300, 10.2133/dmpk.24.300 · DOI
  43. Edwards, 1994, Interactions between fatty acids and lipoprotein lipase. Specific binding and complex formation, Biochemistry, 33, 13304, 10.1021/bi00249a017 · DOI
  44. Bojesen, 1996, Albumin binding of long-chain fatty acids. Thermodynamics and kinetics, J. Phys. Chem., 100, 17981, 10.1021/jp962141m · DOI
  45. Aki, 1994, Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry, J. Pharm. Sci., 83, 1712, 10.1002/jps.2600831213 · DOI
  46. Kersten, 2009, Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids, Arterioscler. Thromb. Vasc. Biol., 29, 969, 10.1161/ATVBAHA.108.182147 · DOI · Paper page
  47. Sanderson, 2009, Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) but not PPARα serves as a plasma free fatty acid sensor in liver, Mol. Cell. Biol., 29, 6257, 10.1128/MCB.00370-09 · DOI
  48. Shimada, 1982, Stabilization of lipoprotein lipase by endothelial cells, Biochem. Biophys. Acta, 710, 117, 10.1016/0005-2760(82)90140-0 · DOI
  49. Saxena, 1989, Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids, J. Biol. Chem., 264, 4349, 10.1016/S0021-9258(18)83748-6 · DOI
  50. Kim, 2006, Role of polyunsaturated fatty acids for misfolding protein aggregations. Implication for neurodegenerative diseases, Ann. N.Y. Acad. Sci., 1086, 11, 10.1196/annals.1377.021 · DOI
  51. Hasegawa, 2008, Growth of β2-microglobulin-related amyloid fibrils by nonesterified fatty acids at a neutral pH, Biochem. J., 416, 307, 10.1042/BJ20080543 · DOI
  52. Demant, 2002, Stopped-flow kinetic analysis of long-chain fatty acid dissociation from bovine serum albumin, Biochem. J., 363, 809, 10.1042/bj3630809 · DOI
  53. Richieri, 1995, Unbound free fatty acid levels in human serum, J. Lipid Res., 36, 229, 10.1016/S0022-2275(20)39899-0 · DOI
  54. Kleinfeld, 1996, Increases in serum unbound free fatty acid levels following coronary angioplasty, Am. J. Cardiol., 78, 1350, 10.1016/S0002-9149(96)00651-0 · DOI
  55. Apple, 2005, Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome, Clin. Chem., 51, 810, 10.1373/clinchem.2004.046292 · DOI
  56. Teusink, 2003, Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake, Diabetes, 52, 614, 10.2337/diabetes.52.3.614 · DOI
  57. Ruby, 2010, VLDL hydrolysis by LPL activates PPAR-α through generation of unbound fatty acids, J. Lipid Res., 51, 2275, 10.1194/jlr.M005561 · DOI
  58. Hultin, 1996, Chylomicron metabolism in rats. Lipolysis, recirculation of triglyceride-derived fatty acids in plasma free fatty acid, and fate of core lipids as analyzed by compartmental modeling, J. Lipid Res., 37, 1022, 10.1016/S0022-2275(20)42012-7 · DOI

Cited by

Sorted by citations

Metadata

Authors
Robal, T., Larsson, M., Martin, M., Olivecrona, G., & Lookene, A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-08
Volume
287
Issue
35
Pages
29739-29752
ISSN
0021-9258
DOI
10.1074/jbc.m111.303529
Cited by
30
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review